It is known that North China Pharmaceutical Croup Corporation (NCPC) have winned New Drug Certificate and Production Approval for Cyclosporin Eye Drops. NCPC is the first enterprise geting the approval of Cyclosporin Eye Drops in China. The drug fill up the blank that there is no high-concentration Cyclosporin ophthalmic formulation.
Cyclosporin is a potent immunosuppressive or anti-rejection drug. It can be used for organ transplant to reduce the risk of organ rejection, otherwize it can be used for amniotic membrane transplantation to reduce the rejection.